ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
BörsenkürzelASPI
Name des UnternehmensASP Isotopes Inc
IPO-datumNov 10, 2022
CEOMr. Paul Elliot Mann
Anzahl der mitarbeiter136
WertpapierartOrdinary Share
GeschäftsjahresendeNov 10
Addresse601 Pennsylvania Avenue Nw
StadtWASHINGTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl20004
Telefon12027562245
Websitehttps://aspisotopes.com/
BörsenkürzelASPI
IPO-datumNov 10, 2022
CEOMr. Paul Elliot Mann
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten